These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6803904)

  • 61. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patients' experiences of chemotherapy treatment.
    Colbourne L
    Prof Nurse; 1995 Apr; 10(7):439-42. PubMed ID: 7724633
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An overview of ondansetron for chemotherapy-induced nausea and emesis.
    San Angel F
    J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

  • 65. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
    Lucas VS; Laszlo J
    JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Models, projects of health participation].
    Scurti V; Sichetti D; Valerio M
    Assist Inferm Ric; 2005; 24(4):204-8. PubMed ID: 16550700
    [No Abstract]   [Full Text] [Related]  

  • 67. IV aprepitant (Cinvanti) for chemotherapy-induced nausea and vomiting.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):e200-e201. PubMed ID: 30653479
    [No Abstract]   [Full Text] [Related]  

  • 68. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ondansetron HCL (Zofran TM, Glaxo).
    Frankiewicz V; Farrington E
    Pediatr Nurs; 1992; 18(4):385-6. PubMed ID: 1387704
    [No Abstract]   [Full Text] [Related]  

  • 70. [Use of Navoban in pediatric oncology].
    Safonova SA; Kolygin BA; Punanov IA; Borodina AF
    Vopr Onkol; 1996; 42(6):72-3. PubMed ID: 9123909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Olanzapine for nausea and vomiting.
    Licup N
    Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract]   [Full Text] [Related]  

  • 73. Evidence to support use of palonosetron over generic serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Yeh YC; Blouin GC; Reddy P
    Am J Health Syst Pharm; 2014 Mar; 71(6):500-6. PubMed ID: 24589541
    [No Abstract]   [Full Text] [Related]  

  • 74. Marijuana as medicine.
    Caswell A
    Med J Aust; 1992 Apr; 156(7):497-8. PubMed ID: 1313533
    [No Abstract]   [Full Text] [Related]  

  • 75. [Nausea and vomiting induced by chemotherapy: bases to a rational treatment].
    Gallardo J; Fodor M
    Rev Med Chil; 1989 Nov; 117(11):1286-94. PubMed ID: 2519807
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimum management of nausea and vomiting in cancer chemotherapy.
    Triozzi PL; Laszlo J
    Drugs; 1987 Jul; 34(1):136-49. PubMed ID: 3308410
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
    Pruitt BT; Justice RL; Periman P
    Tex Med; 1985 Jul; 81(7):44-5. PubMed ID: 3898458
    [No Abstract]   [Full Text] [Related]  

  • 78. Topical capsaicin for cannabinoid hyperemesis syndrome.
    Cruz A; Paloucek FP; Petzel R
    Clin Toxicol (Phila); 2020 Sep; 58(9):938. PubMed ID: 31913735
    [No Abstract]   [Full Text] [Related]  

  • 79. In reply.
    Müller-Vahl K
    Dtsch Arztebl Int; 2013 Mar; 110(10):175. PubMed ID: 23533551
    [No Abstract]   [Full Text] [Related]  

  • 80. Scientific data are lacking.
    Hagmann SG
    Dtsch Arztebl Int; 2013 Mar; 110(10):174. PubMed ID: 23533549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.